TSS
BMY.RT

Two Sigma Securities’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Two Sigma Securities’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,447
Closed -$15K – 1971
2020
Q4 		$15K Buy
+22,447
New +$47.8K ﹤0.01% 1613
2020
Q1 		– Sell
-36,136
Closed -$109K – 2612
2019
Q4 		$109K Buy
+36,136
New +$94K ﹤0.01% 2193

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Two Sigma Securities's BMY.RT Position: Q1 2021 in Review

Two Sigma Securities sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 22,447 shares — an estimated $15K sold.

Two Sigma Securities first reported a position in BMY.RT in Q4 2019 and held it in 2 quarters. The position peaked at $109K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Two Sigma Securities reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Two Sigma Securities sold 22,447 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $15K.
  • Two Sigma Securities first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 2 quarters.
  • Two Sigma Securities's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $109K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Two Sigma Securities's 13F filing for Q1 2021, filed 17 May 2021.